Emergency Center Curbside Screening During the COVID-19 Pandemic: Retrospective Cohort Study.
COVID-19
curbside testing
drive-through testing
emergency center
pandemic
public health
Journal
JMIR public health and surveillance
ISSN: 2369-2960
Titre abrégé: JMIR Public Health Surveill
Pays: Canada
ID NLM: 101669345
Informations de publication
Date de publication:
21 07 2020
21 07 2020
Historique:
received:
10
05
2020
accepted:
02
07
2020
revised:
02
06
2020
pubmed:
4
7
2020
medline:
31
7
2020
entrez:
4
7
2020
Statut:
epublish
Résumé
Coronavirus disease (COVID-19) is a global pandemic that has placed a significant burden on health care systems in the United States. Michigan has been one of the top states affected by COVID-19. We describe the emergency center curbside testing procedure implemented at Beaumont Hospital, a large hospital in Royal Oak, MI, and aim to evaluate its safety and efficiency. Anticipating a surge in patients requiring testing, Beaumont Health implemented curbside testing, operated by a multidisciplinary team of health care workers, including physicians, advanced practice providers, residents, nurses, technicians, and registration staff. We report on the following outcomes over a period of 26 days (March 12, 2020, to April 6, 2020): time to medical decision, time spent documenting electronic medical records, overall screening time, and emergency center return evaluations. In total, 2782 patients received curbside services. A nasopharyngeal swab was performed on 1176 patients (41%), out of whom 348 (29.6%) tested positive. The median time for the entire process (from registration to discharge) was 28 minutes (IQR 17-44). The median time to final medical decision was 15 minutes (IQR 8-27). The median time from medical decision to discharge was 9 minutes (IQR 5-16). Only 257 patients (9.2%) returned to the emergency center for an evaluation within 7 or more days, of whom 64 were admitted to the hospital, 11 remained admitted, and 4 expired. Our curbside testing model encourages the incorporation of this model at other high-volume facilities during an infectious disease pandemic.
Sections du résumé
BACKGROUND
Coronavirus disease (COVID-19) is a global pandemic that has placed a significant burden on health care systems in the United States. Michigan has been one of the top states affected by COVID-19.
OBJECTIVE
We describe the emergency center curbside testing procedure implemented at Beaumont Hospital, a large hospital in Royal Oak, MI, and aim to evaluate its safety and efficiency.
METHODS
Anticipating a surge in patients requiring testing, Beaumont Health implemented curbside testing, operated by a multidisciplinary team of health care workers, including physicians, advanced practice providers, residents, nurses, technicians, and registration staff. We report on the following outcomes over a period of 26 days (March 12, 2020, to April 6, 2020): time to medical decision, time spent documenting electronic medical records, overall screening time, and emergency center return evaluations.
RESULTS
In total, 2782 patients received curbside services. A nasopharyngeal swab was performed on 1176 patients (41%), out of whom 348 (29.6%) tested positive. The median time for the entire process (from registration to discharge) was 28 minutes (IQR 17-44). The median time to final medical decision was 15 minutes (IQR 8-27). The median time from medical decision to discharge was 9 minutes (IQR 5-16). Only 257 patients (9.2%) returned to the emergency center for an evaluation within 7 or more days, of whom 64 were admitted to the hospital, 11 remained admitted, and 4 expired.
CONCLUSIONS
Our curbside testing model encourages the incorporation of this model at other high-volume facilities during an infectious disease pandemic.
Identifiants
pubmed: 32619184
pii: v6i3e20040
doi: 10.2196/20040
pmc: PMC7404008
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e20040Informations de copyright
©Alexandra Halalau, Jeffrey Ditkoff, Jessica Hamilton, Aryana Sharrak, Aimen Vanood, Amr Abbas, James Ziadeh. Originally published in JMIR Public Health and Surveillance (http://publichealth.jmir.org), 21.07.2020.
Références
Emerg Infect Dis. 1999 Sep-Oct;5(5):659-71
pubmed: 10511522
J Autoimmun. 2020 May;109:102433
pubmed: 32113704
Acta Biomed. 2020 Mar 19;91(1):157-160
pubmed: 32191675
J Korean Med Sci. 2020 Mar 23;35(11):e123
pubmed: 32193904